{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:17:17Z","timestamp":1779164237443,"version":"3.51.4"},"reference-count":105,"publisher":"Bentham Science Publishers Ltd.","issue":"18","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Neglected parasitic diseases constitute a broad spectrum of clinical\nconditions that, in the chronic phase, lack effective therapies for the target population.\nThe utilization of vaccines based on liposomal nanocarrier systems is emerging,\nthereby enhancing clinical outcomes in various comorbidities. Consequently, this study\naims to assess the immunological activity induced by liposomal nanocarriers against neglected\nparasitic diseases.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>For the review, the Pubmed, Embase, and Lilacs databases were used using\nthe descriptors vaccine, parasite, and liposome. The following inclusion criteria were\nadopted: in vivo and in vitro experimental articles. As exclusion criteria: book chapters,\neditorials, literature reviews and duplicate articles found during the database search.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>A total of 226 articles were identified, from which 34 were selected for review.\nThe primary diseases identified included Babesia bovis, Entamoeba histolytica, Leishmania\nbraziliensis, Leishmania donovani, Leishmania major, Leishmania infantum, Plasmodium\nfalciparum, Plasmodium chabaudi, Plasmodium chabaudi, Plasmodium yoelii,\nToxoplasma gondii and Trypanosoma cruzi. An elevation in cytokines such as GM-CSF,\nMCP-1, IFN-\u03b3, TNF-\u03b1, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12, and IL-17 was observed in\nthe studies evaluated regarding the parasitic diseases. Furthermore, cytokines such as\nIL-4, IL-10, and TGF-\u03b2 were diminished with the administration of the vaccine systems\nin those studies.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Therefore, the administration of liposomal nanovaccine systems can effectively\nameliorate the clinical condition of patients by modulating their immunological\nprofile.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298673306158240620071438","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T09:59:39Z","timestamp":1720173579000},"page":"3620-3637","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunological Activity of Vaccine Systems Containing Liposomal Nanocarriers against Protozoan-induced Diseases: A Systematic Review"],"prefix":"10.2174","volume":"32","author":[{"given":"Francisco Dantas","family":"Lourenco","sequence":"first","affiliation":[{"name":"Health Science Institute, International Integration University of Afro-Brazilian Lusophony (UNILAB), Reden\u00e7\u00e3o\n- CE, Brazil"},{"name":"Oswaldo Cruz Foundation (FIOCRUZ CEAR\u00c1), Eus\u00e9bio - CE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Victor Lima","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Health Science Institute, International Integration University of Afro-Brazilian Lusophony (UNILAB), Reden\u00e7\u00e3o\n- CE, Brazil"},{"name":"Oswaldo Cruz Foundation (FIOCRUZ CEAR\u00c1), Eus\u00e9bio - CE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel Acacio","family":"de Moura","sequence":"additional","affiliation":[{"name":"Oswaldo Cruz Foundation (FIOCRUZ CEAR\u00c1), Eus\u00e9bio - CE, Brazil"},{"name":"Post-graduate\nProgram in Pharmaceutical Sciences (PPGCF), Federal University of Cear\u00e1 (UFC), Fortaleza-CE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmim Mendes","family":"Rocha","sequence":"additional","affiliation":[{"name":"Oswaldo Cruz Foundation (FIOCRUZ CEAR\u00c1), Eus\u00e9bio - CE, Brazil"},{"name":"Post-graduate\nProgram in Pharmaceutical Sciences (PPGCF), Federal University of Cear\u00e1 (UFC), Fortaleza-CE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joao Pedro Viana","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Oswaldo Cruz Foundation (FIOCRUZ CEAR\u00c1), Eus\u00e9bio - CE, Brazil"},{"name":"Post-graduate\nProgram in Pharmaceutical Sciences (PPGCF), Federal University of Cear\u00e1 (UFC), Fortaleza-CE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana Ramos","family":"de Oliveira","sequence":"additional","affiliation":[{"name":"Oswaldo Cruz Foundation (FIOCRUZ CEAR\u00c1), Eus\u00e9bio - CE, Brazil"},{"name":"Northeast Biotechnology Network (RENORBIO), State University of Cear\u00e1 (UECE), Fortaleza-CE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian Vicson","family":"Pinheiro","sequence":"additional","affiliation":[{"name":"Oswaldo Cruz Foundation (FIOCRUZ CEAR\u00c1), Eus\u00e9bio - CE, Brazil"},{"name":"Post-graduate\nProgram in Pharmaceutical Sciences (PPGCF), Federal University of Cear\u00e1 (UFC), Fortaleza-CE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa Deadame","family":"de Figueiredo Nicolete","sequence":"additional","affiliation":[{"name":"Health Science Institute, International Integration University of Afro-Brazilian Lusophony (UNILAB), Reden\u00e7\u00e3o\n- CE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Nicolete","sequence":"additional","affiliation":[{"name":"Oswaldo Cruz Foundation (FIOCRUZ CEAR\u00c1), Eus\u00e9bio - CE, Brazil"},{"name":"Post-graduate\nProgram in Pharmaceutical Sciences (PPGCF), Federal University of Cear\u00e1 (UFC), Fortaleza-CE, Brazil"},{"name":"Northeast Biotechnology Network (RENORBIO), State University of Cear\u00e1 (UECE), Fortaleza-CE, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"e00215720","DOI":"10.1590\/0102-311x00215720","volume":"36","author":"Luna E.J.A.","year":"2020","unstructured":"Luna E.J.A.; Campos S.R.S.L.C.; O desenvolvimento de vacinas contra as doen\u00e7as tropicais negligenciadas. Cad Saude Publica  2020,36(36)(Suppl. 2),e00215720","journal-title":"Cad Saude Publica"},{"key":"ref=2","unstructured":"World Health Organization. Neglected Tropical Diseases. 2024.  Available from:  https:\/\/www.who.int\/data\/gho\/ data\/themes\/"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"e6512","DOI":"10.1136\/bmj.e6512","volume":"345","author":"Kappagoda S.","year":"2012","unstructured":"Kappagoda S.; Ioannidis J.P.A.; Neglected tropical diseases: survey and geometry of randomised evidence. BMJ  2012,345(oct22 2),e6512","journal-title":"BMJ"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.3390\/ijms23042255","volume":"23","author":"Molehin A.J.","year":"2022","unstructured":"Molehin A.J.; McManus D.P.; You H.; Vaccines for human schistosomiasis: Recent progress, new developments and future prospects. Int J Mol Sci  2022,23(4),2255","journal-title":"Int J Mol Sci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3390\/biomedicines10040831","volume":"10","author":"Rocha V.","year":"2022","unstructured":"Rocha V.; Quadros H.; Meira C.; Silva L.; Carvalho D.; Hodel K.; Moreira D.; Soares M.; Potential of triterpenic natural compound betulinic acid for neglected tropical diseases new treatments. Biomedicines  2022,10(4),831","journal-title":"Biomedicines"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"910236","DOI":"10.3389\/fimmu.2022.910236","volume":"13","author":"Veiga G.T.S.","year":"2023","unstructured":"Veiga G.T.S.; Moriggi M.R.; Vettorazzi J.F.; M\u00fcller-Santos M.; Albrecht L.; Plasmodium vivax vaccine: What is the best way to go? Front Immunol  2023,13,910236","journal-title":"Front Immunol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/82_2020_227","author":"Rao M","year":"2020","unstructured":"Rao M; Peachman K; Alving C.; Liposome formulations as adjuvants for vaccines. Curr Top Biol Immunol  2020,1-28","journal-title":"Curr Top Biol Immunol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"5672","DOI":"10.3390\/molecules25235672","volume":"25","author":"Almeida B.","year":"2020","unstructured":"Almeida B.; Nag O.K.; Rogers K.E.; Delehanty J.B.; Recent progress in bioconjugation strategies for liposome-mediated drug delivery. Molecules  2020,25(23),5672","journal-title":"Molecules"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/pharmaceutics14030543","volume":"14","author":"Lombardo D.","year":"2022","unstructured":"Lombardo D.; Kiselev M.A.; Methods of liposomes preparation: Formation and control factors of versatile nanocarriers for biomedical and nanomedicine application. Pharmaceutics  2022,14(3),543","journal-title":"Pharmaceutics"},{"key":"ref=10","unstructured":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses. 2024.  Available from:  http:\/\/www.prisma- statement.org\/"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.tvjl.2012.10.036","volume":"196","author":"Rodriguez A.E.","year":"2013","unstructured":"Rodriguez A.E.; Zamorano P.; Wilkowsky S.; Torr\u00e1 F.; Ferreri L.; Dominguez M.; Florin-Christensen M.; Delivery of recombinant vaccines against bovine herpesvirus type 1 gD and Babesia bovis MSA-2c to mice using liposomes derived from egg yolk lipids. Vet J  2013,196(3),550-551","journal-title":"Vet J"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.vaccine.2016.12.057","volume":"35","author":"Abhyankar M.M.","year":"2017","unstructured":"Abhyankar M.M.; Noor Z.; Tomai M.A.; Elvecrog J.; Fox C.B.; Petri W.A.; Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica. Vaccine  2017,35(6),916-922","journal-title":"Vaccine"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41541-018-0060-x","volume":"3","author":"Abhyankar M.M.","year":"2018","unstructured":"Abhyankar M.M.; Orr M.T.; Lin S.; Suraju M.O.; Simpson A.; Blust M.; Pham T.; Guderian J.A.; Tomai M.A.; Elvecrog J.; Pedersen K.; Petri W.A.; Fox C.B.; Adjuvant composition and delivery route shape immune response quality and protective efficacy of a recombinant vaccine for Entamoeba histolytica. NPJ Vaccines  2018,3(1),22","journal-title":"NPJ Vaccines"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"601409","DOI":"10.3389\/fchem.2020.601409","volume":"8","author":"Guedes D.C.","year":"2021","unstructured":"Guedes D.C.; Santiani M.H.; Carvalho J.; Soccol C.R.; Minozzo J.C.; Machado de \u00c1vila R.A.; de Moura J.F.; Ramos E.L.P.; Castro G.R.; Ch\u00e1vez-Ol\u00f3rtegi C.; Thomaz-Soccol V.; In silico and in vitro evaluation of mimetic peptides as potential antigen candidates for prophylaxis of leishmaniosis. Front Chem  2021,8,601409","journal-title":"Front Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.apjtm.2015.06.008","volume":"8","author":"Nagill R.","year":"2015","unstructured":"Nagill R.; Kaur T.; Joshi J.; Kaur S.; Immunogenicity and efficacy of recombinant 78 kDa antigen of Leishmania donovani formulated in various adjuvants against murine visceral leishmaniasis. Asian Pac J Trop Med  2015,8(7),513-519","journal-title":"Asian Pac J Trop Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.micinf.2017.09.011","volume":"20","author":"Das P.","year":"2018","unstructured":"Das P.; Paik D.; Naskar K.; Chakraborti T.; Leishmania donovani serine protease encapsulated in liposome elicits protective immunity in experimental visceral leishmaniasis. Microbes Infect  2018,20(1),37-47","journal-title":"Microbes Infect"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fimmu.2018.00018","volume":"9","author":"Sabur A.","year":"2018","unstructured":"Sabur A.; Bhowmick S.; Chhajer R.; Ejazi S.A.; Didwania N.; Asad M.; Bhattacharyya A.; Sinha U.; Ali N.; Liposomal elongation factor-1\u03b1 triggers effector CD4 and CD8 T cells for induction of long-lasting protective immunity against visceral leishmaniasis. Front Immunol  2018,9,18","journal-title":"Front Immunol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.actatropica.2013.07.021","volume":"128","author":"Firouzmand H.","year":"2013","unstructured":"Firouzmand H.; Badiee A.; Khamesipour A.; Heravi Shargh V.; Alavizadeh S.H.; Abbasi A.; Jaafari M.R.; Induction of protection against leishmaniasis in susceptible BALB\/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA). Acta Trop  2013,128(3),528-535","journal-title":"Acta Trop"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"6611","DOI":"10.1016\/j.vaccine.2017.10.039","volume":"35","author":"Wheat W.H.","year":"2017","unstructured":"Wheat W.H.; Arthun E.N.; Spencer J.S.; Regan D.P.; Titus R.G.; Dow S.W.; Immunization against full-length protein and peptides from the Lutzomyia longipalpis sand fly salivary component maxadilan protects against Leishmania major infection in a murine model. Vaccine  2017,35(48),6611-6619","journal-title":"Vaccine"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/08923973.2017.1407941","volume":"40","author":"Firouzmand H.","year":"2018","unstructured":"Firouzmand H.; Sahranavard M.; Badiee A.; Khamesipour A.; Alavizadeh S.H.; Samiei A.; Soroush D.; Tavassoti Kheiri M.; Mahboudi F.; Jaafari M.R.; The role of LPD-nanoparticles containing recombinant major surface glycoprotein of Leishmania (rgp63) in protection against leishmaniasis in murine model. Immunopharmacol Immunotoxicol  2018,40(1),72-82","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"e12492","DOI":"10.1111\/pim.12492","volume":"39","author":"Naseri H.","year":"2017","unstructured":"Naseri H.; Eskandari F.; Jaafari M.R.; Khamesipour A.; Abbasi A.; Badiee A.;  ylation of cationic liposomes encapsulating soluble Leishmania antigens reduces the adjuvant efficacy of liposomes in murine model. Parasite Immunol  2017,39(11),e12492","journal-title":"Parasite Immunol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1080\/21691401.2018.1457042","volume":"46","author":"Emami T.","year":"2018","unstructured":"Emami T.; Rezayat S.M.; Khamesipour A.; Madani R.; Habibi G.; Hojatizade M.; Jaafari M.R.; The role of MPL and imiquimod adjuvants in enhancement of immune response and protection in BALB\/c mice immunized with soluble Leishmania antigen (SLA) encapsulated in nanoliposome. Artif Cells Nanomed Biotechnol  2018,46(sup2),324-333","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.imbio.2017.12.003","volume":"223","author":"Jafari I.","year":"2018","unstructured":"Jafari I.; Heravi Shargh V.; Shahryari M.; Abbasi A.; Jaafari M.R.; Khamesipour A.; Badiee A.; Cationic liposomes formulated with a novel whole Leishmania lysate (WLL) as a vaccine for leishmaniasis in murine model. Immunobiology  2018,223(6-7),493-500","journal-title":"Immunobiology"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"922","DOI":"10.22038\/ijbms.2019.35739.8515","volume":"22","author":"Mehravaran A.","year":"2019","unstructured":"Mehravaran A.; Rezaei Nasab M.; Mirahmadi H.; Sharifi I.; Alijani E.; Nikpoor A.R.; Akhtari J.; Hojatizade M.; Immunogenicity and protection effects of cationic liposome containing imiquimod adjuvant on leishmaniasis in BALB\/c mice. Iran J Basic Med Sci  2019,22(8),922-931","journal-title":"Iran J Basic Med Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.22038\/IJBMS.2020.50471.11496","volume":"24","author":"Biari N.","year":"2021","unstructured":"Biari N.; Alavizadeh S.H.; Chavoshian O.; Abbasi A.; Saberi Z.; Jalali S.A.; Khamesipoure A.; Jaafari M.R.; Badiee A.; Sphingomyelin liposome bearing whole Leishmania lysate antigens induce strong Th2 immune response in BALB\/c mice. Iran J Basic Med Sci  2021,24(2),222-231","journal-title":"Iran J Basic Med Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"102633","DOI":"10.1016\/j.jddst.2021.102633","volume":"64","author":"Zamani P.","year":"2021","unstructured":"Zamani P.; Alavizadeh S.H.; Fakhraee F.; Badiee A.; Jalali S.A.; Chavoshian O.; Khamesipour A.; Kheiri M.T.; Mahboudi F.; Jaafari M.R.; Multi-antigen vaccination with LPD nanoparticles containing rgp63 and rLmaC1N proteins induced effective immune response against leishmaniasis in animal model. J Drug Deliv Sci Technol  2021,64,102633","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13071-015-0747-z","volume":"8","author":"Toledo-Machado C.M.","year":"2015","unstructured":"Toledo-Machado C.M.; Bueno L.L.; Menezes-Souza D.; Machado-de-Avila R.A.; Nguyen C.; Granier C.; Bartholomeu D.C.; Ch\u00e1vez-Ol\u00f3rtegui C.; Fujiwara R.T.; Use of Phage Display technology in development of canine visceral leishmaniasis vaccine using synthetic peptide trapped in sphingomyelin\/cholesterol liposomes. Parasit Vectors  2015,8(1),133","journal-title":"Parasit Vectors"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cyto.2018.08.019","volume":"111","author":"Ribeiro P.A.F.","year":"2018","unstructured":"Ribeiro P.A.F.; Dias D.S.; Novais M.V.M.; Lage D.P.; Tavares G.S.V.; Mendon\u00e7a D.V.C.; Oliveira J.S.; Ch\u00e1vez-Fumagalli M.A.; Roatt B.M.; Duarte M.C.; Menezes-Souza D.; Ludolf F.; Tavares C.A.P.; Oliveira M.C.; Coelho E.A.F.; Coelho M.; A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis. Cytokine  2018,111,131-139","journal-title":"Cytokine"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3390\/vaccines8020289","volume":"8","author":"Lage D.P.","year":"2020","unstructured":"Lage D.P.; Ribeiro P.A.F.; Dias D.S.; Mendon\u00e7a D.V.C.; Ramos F.F.; Carvalho L.M.; Steiner B.T.; Tavares G.S.V.; Martins V.T.; Machado A.S.; Oliveira-da-Silva J.A.; Santos T.T.O.; Freitas C.S.; Oliveira J.S.; Roatt B.M.; Machado-de-\u00c1vila R.A.; Humbert M.V.; Christodoulides M.; Coelho E.A.F.; Liposomal formulation of chimerat, a multiple T-cell epitope-containing recombinant protein, is a candidate vaccine for human visceral leishmaniasis. Vaccines  2020,8(2),289","journal-title":"Vaccines"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"155031","DOI":"10.1016\/j.cyto.2020.155031","volume":"129","author":"Ribeiro P.A.F.","year":"2020","unstructured":"Ribeiro P.A.F.; Vale D.L.; Dias D.S.; Lage D.P.; Mendon\u00e7a D.V.C.; Ramos F.F.; Carvalho L.M.; Carvalho A.M.R.S.; Steiner B.T.; Roque M.C.; Oliveira-da-Silva J.A.; Oliveira J.S.; Tavares G.S.V.; Galvani N.C.; Martins V.T.; Ch\u00e1vez-Fumagalli M.A.; Roatt B.M.; Moreira R.L.F.; Menezes-Souza D.; Oliveira M.C.; Machado-de-\u00c1vila R.A.; Teixeira A.L.; Coelho E.A.F.; Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis. Cytokine  2020,129,155031","journal-title":"Cytokine"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"e00498-16","DOI":"10.1128\/IAI.00498-16","volume":"85","author":"Espinosa D.A.","year":"2017","unstructured":"Espinosa D.A.; Vega-Rodriguez J.; Flores-G\u00e1rcia Y.; Noe A.R.; Mu\u00f1oz C.; Coleman R.; Bruck T.; Haney K.; Stevens A.; Retallack D.; Allen J.; Vedvick T.S.; Fox C.B.; Reed S.G.; Howard R.F.; Salman A.M.; Janse C.J.; Khan S.M.; Zavala F.; Gutierrez G.M.; The plasmodium falciparum cell-traversal protein for ookinetes and sporozoites as a candidate for preerythrocytic and transmission-blocking vaccines. Infect Immun  2017,85(2),e00498-16","journal-title":"Infect Immun"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtm.2017.08.004","volume":"7","author":"Fotoran W.L.","year":"2017","unstructured":"Fotoran W.L.; Santangelo R.; de Miranda B.N.M.; Irvine D.J.; Wunderlich G.; DNA-loaded cationic liposomes efficiently function as a vaccine against malarial proteins. Mol Ther Methods Clin Dev  2017,7(7),1-10","journal-title":"Mol Ther Methods Clin Dev"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1016\/j.vaccine.2019.05.059","volume":"37","author":"Cawlfield A.","year":"2019","unstructured":"Cawlfield A.; Genito C.J.; Beck Z.; Bergmann-Leitner E.S.; Bitzer A.A.; Soto K.; Zou X.; Hadiwidjojo S.H.; Gerbasi R.V.; Mullins A.B.; Noe A.; Waters N.C.; Alving C.R.; Matyas G.R.; Dutta S.; Safety, toxicity and immunogenicity of a malaria vaccine based on the circumsporozoite protein (FMP013) with the adjuvant army liposome formulation containing QS21 (ALFQ). Vaccine  2019,37(29),3793-3803","journal-title":"Vaccine"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3390\/vaccines8040619","volume":"8","author":"Fotoran W.L.","year":"2020","unstructured":"Fotoran W.L.; Kleiber N.; Glitz C.; Wunderlich G.; A DNA vaccine encoding Plasmodium falciparum PfRH5 in cationic liposomes for dermal tattooing immunization. Vaccines  2020,8(4),619","journal-title":"Vaccines"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1016\/j.vaccine.2019.11.063","volume":"38","author":"Ssemaganda A.","year":"2020","unstructured":"Ssemaganda A.; Giddam A.K.; Low L.M.; Liu X.Q.; Ho M.F.; Zaman M.; Hussein W.M.; Skwarczynski M.; Toth I.; Stanisic D.I.; Good M.F.; Mannosylated liposomes formulated with whole parasite P. falciparum blood-stage antigens are highly immunogenic in mice. Vaccine  2020,38(6),1494-1504","journal-title":"Vaccine"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/nano11020406","volume":"11","author":"Chaudhari R.","year":"2021","unstructured":"Chaudhari R.; Tandel N.; Sahu K.; Negi S.; Bashir H.; Rupareliya A.; Mishra R.P.N.; Dalai S.K.; Tyagi R.K.; Transdermal immunization of elastic liposome-laden recombinant chimeric fusion protein of P. falciparum (PfMSP-Fu) mounts protective immune response. Nanomaterials  2021,11(2),406","journal-title":"Nanomaterials"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/j.vaccine.2021.02.010","volume":"39","author":"Das S.C.","year":"2021","unstructured":"Das S.C.; Price J.D.; Gosling K.; MacLennan N.; Ata\u00edde R.; Seow J.; Irani V.; Atmosukarto I.I.; Anders R.F.; Richards J.S.; MacRaild C.A.; Norton R.S.; Liposome engraftment and antigen combination potentiate the immune response towards conserved epitopes of the malaria vaccine candidate MSP2. Vaccine  2021,39(12),1746-1757","journal-title":"Vaccine"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s42003-022-03688-z","volume":"5","author":"Huang W.C.","year":"2022","unstructured":"Huang W.C.; Mabrouk M.T.; Zhou L.; Baba M.; Tachibana M.; Torii M.; Takashima E.; Locke E.; Plieskatt J.; King C.R.; Coelho C.H.; Duffy P.E.; Long C.; Tsuboi T.; Miura K.; Wu Y.; Ishino T.; Lovell J.F.; Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages. Commun Biol  2022,5(1),773","journal-title":"Commun Biol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"e0264961","DOI":"10.1371\/journal.pone.0264961","volume":"17","author":"Islam M.T.","year":"2022","unstructured":"Islam M.T.; Ho M.F.; Nahar U.J.; Shalash A.O.; Koirala P.; Hussein W.M.; Stanisic D.I.; Good M.F.; Skwarczynski M.; Toth I.; Investigation of liposomal self-adjuvanting peptide epitopes derived from conserved blood-stage Plasmodium antigens. PLoS One  2022,17(3),e0264961","journal-title":"PLoS One"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.actbio.2016.08.020","volume":"44","author":"Giddam A.K.","year":"2016","unstructured":"Giddam A.K.; Reiman J.M.; Zaman M.; Skwarczynski M.; Toth I.; Good M.F.; A semi-synthetic whole parasite vaccine designed to protect against blood stage malaria. Acta Biomater  2016,44(15),295-303","journal-title":"Acta Biomater"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"e0265721","DOI":"10.1128\/mBio.02657-21","volume":"12","author":"Stanisic D","year":"2021","unstructured":"Stanisic D; Ho M; Nevagi R; Cooper E; Walton M; Islam M; Hussein W; Skwarcynski M; Toth I; Good M.; Development and evaluation of a cryopreserved whole-parasite vaccine in a rodent model of blood-stage malaria. mBio  2021,12(5),e0265721","journal-title":"mBio"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.vaccine.2014.01.095","volume":"32","author":"Tanaka S.","year":"2014","unstructured":"Tanaka S.; Kuroda Y.; Ihara F.; Nishimura M.; Hiasa J.; Kojima N.; Nishikawa Y.; Vaccination with profilin encapsulated in oligomannose-coated liposomes induces significant protective immunity against Toxoplasma gondii. Vaccine  2014,32(16),1781-1785","journal-title":"Vaccine"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"105016","DOI":"10.1016\/j.micpath.2021.105016","volume":"158","author":"Karakavuk M.","year":"2021","unstructured":"Karakavuk M.; Can H.; G\u00fcl A.; D\u00f6\u015fkaya A.D.; Alak S.E.; \u00dcn C.; G\u00fcr\u00fcz A.Y.; D\u00f6\u015fkaya M.; GRA8 DNA vaccine formulations protect against chronic toxoplasmosis. Microb Pathog  2021,158,105016","journal-title":"Microb Pathog"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"409","DOI":"10.4161\/hv.22780","volume":"9","author":"Higa L.","year":"2013","unstructured":"Higa L.; Corral S.; Morilla M.; Romero E.; Petray P.; Arqueossomos apresentam potencial imunoadjuvante para vacina contra doen\u00e7a de Chagas. Hum Vaccin Immunother  2013,9(2),409-412","journal-title":"Hum Vaccin Immunother"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3390\/vaccines10040505","volume":"10","author":"Sengupta A","year":"2022","unstructured":"Sengupta A; Azharuddin M; Al-Otaibi N; Hinkula J.; Efficacy and immune response elicited by gold nanoparticle-based nanovaccines against infectious diseases. Vaccines  2022,10(4),505","journal-title":"Vaccines"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"729086","DOI":"10.3389\/fimmu.2021.729086","volume":"12","author":"Howard G","year":"2021","unstructured":"Howard G; Bender N; Khare P; Gutierrez B; Nyasembe V; Weiss W; Simecka J; Hamerl T; Mao H; Dinglansan R.; Immunopotentiation by lymph-node targeting of a malaria transmission-blocking nanovaccine. Front Immunol  2021,12,729086","journal-title":"Front Immunol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","volume":"9","author":"Lee A.J.","year":"2018","unstructured":"Lee A.J.; Ashkar A.A.; The dual nature of type I and type II interferons. Front Immunol  2018,9,2061","journal-title":"Front Immunol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12881-020-01043-9","volume":"21","author":"Ahmed A.A.","year":"2020","unstructured":"Ahmed A.A.; Rasheed Z.; Salem T.; Al-Dhubaibi M.S.; Al Robaee A.A.; Alzolibani A.A.; TNF-\u03b1 : 308 G\/A and IFN-\u03b3 + 874 A\/T gene polymorphisms in Saudi patients with cutaneous leishmaniasis. BMC Med Genet  2020,21(1),104","journal-title":"BMC Med Genet"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","volume":"23","author":"Mills K.H.G.","year":"2023","unstructured":"Mills K.H.G.; IL-17 and IL-17-producing cells in protection versus pathology. Nat Rev Immunol  2023,23(1),38-54","journal-title":"Nat Rev Immunol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.25122\/jml-2021-0328","volume":"15","author":"Hadi W.S.","year":"2022","unstructured":"Hadi W.S.; Salman R.S.; Al-Fahham A.A.; Faryad Khan M.U.; Kadir S.; Laft M.H.; Saeed B.Q.; Kadhum W.R.; Jalil A.T.; Kadhim M.M.; Evaluation of IL-17 and IL-35 in patients with giardiasis in Thi-Qar province, Iraq. J Med Life  2022,15(9),1096-1099","journal-title":"J Med Life"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/9394585","volume":"2020","author":"Aninagyei E.","year":"2020","unstructured":"Aninagyei E.; Adu P.; Egyir-Yawson A.; Acheampong D.O.; Elevated IL-12, TNF-\u03b1, and TNF-\u03b1\/IL-10 ratios in stored Plasmodium falciparum-infected whole blood: Implications for safe haemotransfusion. J Immunol Res  2020,2020,1-10","journal-title":"J Immunol Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"e0008021","DOI":"10.1371\/journal.pntd.0008021","volume":"14","author":"Costa S.F.","year":"2020","unstructured":"Costa S.F.; Gomes V.O.; dos Santos Maciel M.O.; Melo L.M.; Venturin G.L.; Bragato J.P.; Rebech G.T.; de Oliveira Santos C.; Nascimento de Oliveira B.M.; Gileno de S\u00e1 Oliveira G.; Felix de Lima V.M.; Combined in vitro IL-12 and IL-15 stimulation promotes cellular immune response in dogs with visceral leishmaniasis. PLoS Negl Trop Dis  2020,14(1),e0008021","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"e20212434","DOI":"10.1084\/jem.20212434","volume":"219","author":"Shemesh A.","year":"2022","unstructured":"Shemesh A.; Pickering H.; Roybal K.T.; Lanier L.L.; Differential IL-12 signaling induces human natural killer cell activating receptor-mediated ligand-specific expansion. J Exp Med  2022,219(8),e20212434","journal-title":"J Exp Med"},{"key":"ref=54","first-page":"340","volume":"12","author":"Rousseau D.","year":"2001","unstructured":"Rousseau D.; Demartino S.; Anju\u00e8re F.; Ferrua B.; Fragaki K.; Le Fichoux Y.; Kubar J.; Sustained parasite burden in the spleen of Leishmania infantum-infected BALB\/c mice is accompanied by expression of MCP-1 transcripts and lack of protection against challenge. Eur Cytokine Netw  2001,12(2),340-347","journal-title":"Eur Cytokine Netw"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3390\/medicina58091266","volume":"58","author":"Imani M.M.","year":"2022","unstructured":"Imani M.M.; Sadeghi M.; Mohammadi M.; Br\u00fchl A.B.; Sadeghi-Bahmani D.; Brand S.; Association of blood MCP-1 levels with risk of obstructive sleep apnea: A systematic review and meta-analysis. Medicina  2022,58(9),1266","journal-title":"Medicina"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/15459683211001026","volume":"35","author":"Daines J.M.","year":"2021","unstructured":"Daines J.M.; Schellhardt L.; Wood M.D.; The role of the IL-4 signaling pathway in traumatic nerve injuries. Neurorehabil Neural Repair  2021,35(5),431-443","journal-title":"Neurorehabil Neural Repair"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.immuni.2022.10.004","volume":"55","author":"Czimmerer Z.","year":"2022","unstructured":"Czimmerer Z.; Halasz L.; Daniel B.; Varga Z.; Bene K.; Domokos A.; Hoeksema M.; Shen Z.; Berger W.K.; Cseh T.; Jambrovics K.; Kolostyak Z.; Fenyvesi F.; Varadi J.; Poliska S.; Hajas G.; Szatmari I.; Glass C.K.; Bacsi A.; Nagy L.; The epigenetic state of IL-4-polarized macrophages enables inflammatory cistromic expansion and extended synergistic response to TLR ligands. Immunity  2022,55(11),2006-2026.e6","journal-title":"Immunity"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"216","DOI":"10.4314\/ahs.v22i2.25","volume":"22","author":"Afshan K.","year":"2022","unstructured":"Afshan K.; Sarfraz K.; Kayani T.; Firasat S.; IL-4 gene polymorphisms and their association with nematodes infection in Pakistani population. Afr Health Sci  2022,22(2),216-228","journal-title":"Afr Health Sci"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.1128\/iai.59.12.4710-4714.1991","volume":"59","author":"Sadick M.D.","year":"1991","unstructured":"Sadick M.D.; Street N.; Mosmann T.R.; Locksley R.M.; Cytokine regulation of murine leishmaniasis: Interleukin 4 is not sufficient to mediate progressive disease in resistant C57BL\/6 mice. Infect Immun  1991,59(12),4710-4714","journal-title":"Infect Immun"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"e20190418","DOI":"10.1084\/jem.20190418","volume":"217","author":"Saraiva M.","year":"2020","unstructured":"Saraiva M.; Vieira P.; O\u2019Garra A.; Biology and therapeutic potential of interleukin-10. J Exp Med  2020,217(1),e20190418","journal-title":"J Exp Med"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.4269\/ajtmh.20-0531","volume":"103","author":"Murray H.W.","year":"2020","unstructured":"Murray H.W.; Targeting IL-27 and\/or IL-10 in experimental murine visceral leishmaniasis. Am J Trop Med Hyg  2020,103(5),1938-1941","journal-title":"Am J Trop Med Hyg"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"e0004422","DOI":"10.1371\/journal.pntd.0004422","volume":"10","author":"Bhattacharya P.","year":"2016","unstructured":"Bhattacharya P.; Ghosh S.; Ejazi S.A.; Rahaman M.; Pandey K.; Ravi Das V.N.; Das P.; Goswami R.P.; Saha B.; Ali N.; Induction of IL-10 and TGF\u03b2 from CD4CD25FoxP3 T cells correlates with parasite load in indian kala-azar patients infected with Leishmania donovani. PLoS Negl Trop Dis  2016,10(2),e0004422","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"108515","DOI":"10.1016\/j.clim.2020.108515","volume":"218","author":"Damoiseaux J.","year":"2020","unstructured":"Damoiseaux J.; The IL-2 \u2013 IL-2 receptor pathway in health and disease: The role of the soluble IL-2 receptor. Clin Immunol  2020,218,108515","journal-title":"Clin Immunol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"13115","DOI":"10.1038\/s41598-020-70102-1","volume":"10","author":"Kupz A.","year":"2020","unstructured":"Kupz A.; Pai S.; Giacomin P.R.; Whan J.A.; Walker R.A.; Hammoudi P.M.; Smith N.C.; Miller C.M.; Treatment of mice with S4B6 IL-2 complex prevents lethal toxoplasmosis via IL-12- and IL-18-dependent interferon-gamma production by non-CD4 immune cells. Sci Rep  2020,10(1),13115","journal-title":"Sci Rep"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"e200080","DOI":"10.1590\/0074-02760200080","volume":"115","author":"Costa A","year":"2020","unstructured":"Costa A; Chaves Y; Carvalho A; Ramasawmy R; Antonelli L; Barbosa L; Balieiro A; Monteiro W; Mour\u00e3o M; Lacerda M; Filho O; Costa F; Malheiro A; Nogueira P.; Increased platelet distribution width and reduced IL-2 and IL-12 are associated with thrombocytopenia in Plasmodium vivax malaria. Mem Int Oswaldo Cruz  2020,115,e200080","journal-title":"Mem Int Oswaldo Cruz"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"e42791","DOI":"10.7759\/cureus.42791","volume":"15","author":"Chokshi A.","year":"2023","unstructured":"Chokshi A.; Demory Beckler M.; Laloo A.; Kesselman M.M.; Paradoxical tumor necrosis factor-alpha (TNF-\u03b1) inhibitor-induced psoriasis: A systematic review of pathogenesis, clinical presentation, and treatment. Cureus  2023,15(8),e42791","journal-title":"Cureus"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","volume":"21","author":"Peng D.","year":"2022","unstructured":"Peng D.; Fu M.; Wang M.; Wei Y.; Wei X.; Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy. Mol Cancer  2022,21(1),104","journal-title":"Mol Cancer"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"901277","DOI":"10.3389\/fimmu.2022.901277","volume":"13","author":"Kumar A.","year":"2022","unstructured":"Kumar A.; Taghi Khani A.; Sanchez Ortiz A.; Swaminathan S.; GM-CSF: A double-edged sword in cancer immunotherapy. Front Immunol  2022,13,901277","journal-title":"Front Immunol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s10875-023-01451-5","volume":"43","author":"Arango-Franco C.A.","year":"2023","unstructured":"Arango-Franco C.A.; Migaud M.; Ram\u00edrez-S\u00e1nchez I.C.; Arango-Bustamante K.; Moncada-V\u00e9lez M.; Rojas J.; Gervais A.; Pati\u00f1o-Giraldo S.; Perez-Zapata L.J.; \u00c1lvarez \u00c1lvarez J.A.; Orrego J.C.; Roncancio-Villamil G.; Boisson-Dupuis S.; Jouanguy E.; Abel L.; Casanova J.L.; Bustamante J.; Arias A.A.; Franco J.L.; Puel A.; Anti-GM-CSF neutralizing autoantibodies in colombian patients with disseminated cryptococcosis. J Clin Immunol  2023,43(5),921-932","journal-title":"J Clin Immunol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1111\/cea.13885","volume":"51","author":"Principe S.","year":"2021","unstructured":"Principe S.; Porsbjerg C.; Bolm Ditlev S.; Kj\u00e6rsgaard Klein D.; Golebski K.; Dyhre-Petersen N.; van Dijk Y.E.; van Bragt J.J.M.H.; Dankelman L.L.H.; Dahlen S.E.; Brightling C.E.; Vijverberg S.J.H.; Maitland-van der Zee A.H.; Treating severe asthma: Targeting the IL-5 pathway. Clin Exp Allergy  2021,51(8),992-1005","journal-title":"Clin Exp Allergy"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2478\/v10042-009-0013-3","volume":"47","author":"Matowicka-Karna J.","year":"2009","unstructured":"Matowicka-Karna J.; Dymicka-Piekarska V.; Kemona H.; IFN-gamma, IL-5, IL-6 and IgE in patients infected with Giardia intestinalis. Folia Histochem Cytobiol  2009,47(1),93-97","journal-title":"Folia Histochem Cytobiol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"e2658","DOI":"10.1371\/journal.pntd.0002658","volume":"8","author":"Anuradha R.","year":"2014","unstructured":"Anuradha R.; George P.J.; Hanna L.E.; Chandrasekaran V.; Kumaran P.P.; Nutman T.B.; Babu S.; Parasite-antigen driven expansion of IL-5(-) and IL-5(+) Th2 human subpopulations in lymphatic filariasis and their differential dependence on IL-10 and TGF\u03b2. PLoS Negl Trop Dis  2014,8(1),e2658","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1143012","DOI":"10.3389\/fimmu.2023.1143012","volume":"14","author":"Belhimeur S.","year":"2023","unstructured":"Belhimeur S.; Briquet S.; Peronet R.; Pham J.; Commer\u00e9 P.H.; Formaglio P.; Amino R.; Scherf A.; Silvie O.; Mecheri S.; Plasmodium-encoded murine IL-6 impairs liver stage infection and elicits long-lasting sterilizing immunity. Front Immunol  2023,14,1143012","journal-title":"Front Immunol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/9754060","volume":"2018","author":"Mutengo M.M.","year":"2018","unstructured":"Mutengo M.M.; Mduluza T.; Kelly P.; Mwansa J.C.L.; Kwenda G.; Musonda P.; Chipeta J.; Low IL-6, IL-10, and TNF- \u03b1 and High IL-13 cytokine levels are associated with severe hepatic fibrosis in Schistosoma mansoni chronically exposed individuals. J Parasitol Res  2018,2018,1-8","journal-title":"J Parasitol Res"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"e20190347","DOI":"10.1084\/jem.20190347","volume":"217","author":"Kang S.","year":"2020","unstructured":"Kang S.; Narazaki M.; Metwally H.; Kishimoto T.; Historical overview of the interleukin-6 family cytokine. J Exp Med  2020,217(5),e20190347","journal-title":"J Exp Med"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s12879-020-05107-2","volume":"20","author":"Le\u00e3o L.","year":"2020","unstructured":"Le\u00e3o L.; Puty B.; Dolabela M.F.; Povoa M.M.; N\u00e9 Y.G.D.S.; Eir\u00f3 L.G.; Fagundes N.C.F.; Maia L.C.; Lima R.R.; Association of cerebral malaria and TNF-\u03b1 levels: A systematic review. BMC Infect Dis  2020,20(1),442","journal-title":"BMC Infect Dis"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3390\/molecules24030516","volume":"24","author":"Pereira-Leite C.","year":"2019","unstructured":"Pereira-Leite C.; Lopes-de-Campos D.; Fontaine P.; Cuccovia I.; Nunes C.; Reis S.; Licofelone-DPPC Interactions: Putting membrane lipids on the radar of drug development. Molecules  2019,24(3),516","journal-title":"Molecules"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1529\/biophysj.105.076596","volume":"90","author":"Leekumjorn S.","year":"2006","unstructured":"Leekumjorn S.; Sum A.K.; Molecular simulation study of structural and dynamic properties of mixed DPPC\/DPPE bilayers. Biophys J  2006,90(11),3951-3965","journal-title":"Biophys J"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3389\/fmicb.2018.01427","volume":"9","author":"dos Santos I.B.","year":"2018","unstructured":"dos Santos I.B.; da Silva D.A.M.; Paz F.A.C.R.; Garcia D.M.; Carmona A.K.; Teixeira D.; Longo-Maug\u00e9ri I.M.; Katz S.; Barbi\u00e9ri C.L.; Leishmanicidal and immunomodulatory activities of the palladacycle complex DPPE 1.1, a potential candidate for treatment of cutaneous leishmaniasis. Front Microbiol  2018,9,1427","journal-title":"Front Microbiol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1046\/j.1365-2249.2001.01479.x","volume":"124","author":"Tonks A.","year":"2002","unstructured":"Tonks A.; Morris R.H.K.; Price A.J.; Thomas A.W.; Jones K.P.; Jackson S.K.; Dipalmitoylphosphatidylcholine modulates inflammatory functions of monocytic cells independently of mitogen activated protein kinases. Clin Exp Immunol  2002,124(1),86-94","journal-title":"Clin Exp Immunol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12951-024-02345-3","volume":"22","author":"Wang S.","year":"2024","unstructured":"Wang S.; Ding P.; Shen L.; Fan D.; Cheng H.; Huo J.; Wei X.; He H.; Zhang G.; Inhalable hybrid nanovaccines with virus-biomimetic structure boost protective immune responses against SARS-CoV-2 variants. J Nanobiotechnology  2024,22(1),76","journal-title":"J Nanobiotechnology"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ejps.2012.06.015","volume":"47","author":"Rattanakiat S.","year":"2012","unstructured":"Rattanakiat S.; Nishikawa M.; Takakura Y.; Self-assembling CpG DNA nanoparticles for efficient antigen delivery and immunostimulation. Eur J Pharm Sci  2012,47(2),352-358","journal-title":"Eur J Pharm Sci"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"8402","DOI":"10.1039\/C9SM01464K","volume":"15","author":"Tsagkaropoulou G.","year":"2019","unstructured":"Tsagkaropoulou G.; Allen F.J.; Clarke S.M.; Camp P.J.; Self-assembly and adsorption of cetyltrimethylammonium bromide and didodecyldimethylammonium bromide surfactants at the mica\u2013water interface. Soft Matter  2019,15(41),8402-8411","journal-title":"Soft Matter"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"111020","DOI":"10.1016\/j.micromeso.2021.111020","volume":"318","author":"Rakhym A.B.","year":"2021","unstructured":"Rakhym A.B.; Seilkhanova G.A.; Mastai Y.; Physicochemical evaluation of the effect of natural zeolite modification with didodecyldimethylammonium bromide on the adsorption of bisphenol-A and propranolol hydrochloride. Microporous Mesoporous Mater  2021,318,111020","journal-title":"Microporous Mesoporous Mater"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/s41565-021-00950-z","volume":"16","author":"Wang Z.","year":"2021","unstructured":"Wang Z.; Little N.; Chen J.; Lambesis K.T.; Le K.T.; Han W.; Scott A.J.; Lu J.; Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy. Nat Nanotechnol  2021,16(10),1130-1140","journal-title":"Nat Nanotechnol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"119043","DOI":"10.1016\/j.bbamcr.2021.119043","volume":"1868","author":"Koide N.","year":"2021","unstructured":"Koide N.; Fujita K.; Kuroda S.; Hinuma S.; Binding of liposomes composed of phosphatidylcholine to scavenger receptor class B type 1 and its modulation by phosphatidic acid in HEK293T cells. Biochim Biophys Acta Mol Cell Res  2021,1868(7),119043","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1208\/s12249-022-02294-w","volume":"23","author":"Sun M","year":"2022","unstructured":"Sun M; Dang U; Yuan Y; Psaras A; Osipitan O; Brooks T; Lu F; Pasqua A.; Optimization of DOTAP\/Chol cationic lipid nanoparticles for mRNA, pDNA, and oligonucleotide delivery. AAPS Pharm Sci Tech  2022,23(5),135","journal-title":"AAPS Pharm Sci Tech"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1166\/jbn.2014.1991","volume":"10","author":"Prashant C.K.","year":"2014","unstructured":"Prashant C.K.; Kumar M.; Dinda A.K.; Nanoparticle based tailoring of adjuvant function: The role in vaccine development. J Biomed Nanotechnol  2014,10(9),2317-2331","journal-title":"J Biomed Nanotechnol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.4049\/jimmunol.1801634","volume":"202","author":"Gandhapudi S.K.","year":"2019","unstructured":"Gandhapudi S.K.; Ward M.; Bush J.P.C.; Bedu-Addo F.; Conn G.; Woodward J.G.; Antigen priming with enantiospecific cationic lipid nanoparticles induces potent antitumor CTL responses through novel induction of a type I IFN response. J Immunol  2019,202(12),3524-3536","journal-title":"J Immunol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1016\/j.vaccine.2009.04.054","volume":"27","author":"Lay M.","year":"2009","unstructured":"Lay M.; Callejo B.; Chang S.; Hong D.K.; Lewis D.B.; Carroll T.D.; Matzinger S.; Fritts L.; Miller C.J.; Warner J.F.; Liang L.; Fairman J.; Cationic lipid\/DNA complexes (JVRS-100) combined with influenza vaccine (Fluzone) increases antibody response, cellular immunity, and antigenically drifted protection. Vaccine  2009,27(29),3811-3820","journal-title":"Vaccine"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1128\/IAI.72.3.1608-1617.2004","volume":"72","author":"Holten-Andersen L.","year":"2004","unstructured":"Holten-Andersen L.; Doherty T.M.; Korsholm K.S.; Andersen P.; Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines. Infect Immun  2004,72(3),1608-1617","journal-title":"Infect Immun"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fcell.2019.00152","volume":"7","author":"Avota E.","year":"2019","unstructured":"Avota E.; de Lira M.N.; Schneider-Schaulies S.; Sphingomyelin breakdown in T Cells: Role of membrane compartmentalization in T cell signaling and interference by a pathogen. Front Cell Dev Biol  2019,7,152","journal-title":"Front Cell Dev Biol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"e867","DOI":"10.1002\/iid3.867","volume":"11","author":"Moradi M.","year":"2023","unstructured":"Moradi M.; Vahedi F.; Abbassioun A.; Ramezanpour Shahi A.; Sholeh M.; Taheri-Anganeh M.; Dargahi Z.; Ghanavati R.; Khatami S.H.; Movahedpour A.; Liposomal delivery system\/adjuvant for tuberculosis vaccine. Immun Inflamm Dis  2023,11(6),e867","journal-title":"Immun Inflamm Dis"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"409","DOI":"10.5114\/bta.2022.120709","volume":"103","author":"Krasnopolsky Y.","year":"2022","unstructured":"Krasnopolsky Y.; Pylypenko D.; Licensed liposomal vaccines and adjuvants in the antigen delivery system. Biotechnologia  2022,103(4),409-423","journal-title":"Biotechnologia"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3892\/ijo.32.5.1119","volume":"32","author":"Thangapazham R.","year":"2008","unstructured":"Thangapazham R.; Puri A.; Tele S.; Blumenthal R.; Maheshwari R.; Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. Int J Oncol  2008,32(5),1119-1123","journal-title":"Int J Oncol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"10735","DOI":"10.3390\/ijms231810735","volume":"23","author":"Andr\u00e9s C.M.C.","year":"2022","unstructured":"Andr\u00e9s C.M.C.; P\u00e9rez de la Lastra J.M.; Juan C.A.; Plou F.J.; P\u00e9rez-Lebe\u00f1a E.; Hypochlorous acid chemistry in mammalian cells-influence on infection and role in various pathologies. Int J Mol Sci  2022,23(18),10735","journal-title":"Int J Mol Sci"},{"key":"ref=97","unstructured":"PubChem. DDBA Available from:  https:\/\/pubchem. ncbi.nlm.nih.gov\/compound\/77293 (Accessed on May 12,2024)."},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.bbamem.2006.11.013","volume":"1768","author":"Elvington S.M.","year":"2007","unstructured":"Elvington S.M.; Nichols J.W.; Spontaneous, intervesicular transfer rates of fluorescent, acyl chain-labeled phosphatidylcholine analogs. Biochim Biophys Acta Biomembr  2007,1768(3),502-508","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.2147\/IJN.S125866","volume":"12","author":"Gao J.","year":"2017","unstructured":"Gao J.; Ochyl L.; Yang E.; Moon J.; Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens. Int J Nanomedicine  2017,12,1251-1264","journal-title":"Int J Nanomedicine"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.3762\/bjoc.8.46","author":"Boettcher S.","year":"2017","unstructured":"Boettcher S.; Matwiejuk M.; Thiem J.; Acceptor-influenced and donor-tuned base-promoted glycosylation. Beilstein J Org Chem  2017,1251-1264","journal-title":"Beilstein J Org Chem"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"7458","DOI":"10.1021\/acs.jmedchem.3c02385","volume":"67","author":"Rohokale R.","year":"2024","unstructured":"Rohokale R.; Guo J.; Guo Z.; Monophosphoryl lipid a rhamnose conjugates as a new class of vaccine adjuvants. J Med Chem  2024,67(9),7458-7469","journal-title":"J Med Chem"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"33385","DOI":"10.1039\/C7RA04284A","volume":"7","author":"Tang J.","year":"2017","unstructured":"Tang J.; He J.; Liu T.; Xin X.; Removal of heavy metals with sequential sludge washing techniques using saponin: Optimization conditions, kinetics, removal effectiveness, binding intensity, mobility and mechanism. RSC Advances  2017,7(53),33385-33401","journal-title":"RSC Advances"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1074\/jbc.M115.683011","volume":"291","author":"Marty-Roix R.","year":"2016","unstructured":"Marty-Roix R.; Vladimer G.I.; Pouliot K.; Weng D.; Buglione-Corbett R.; West K.; MacMicking J.D.; Chee J.D.; Wang S.; Lu S.; Lien E.; Identification of QS-21 as an inflammasome-activating molecular component of saponin adjuvants. J Biol Chem  2016,291(3),1123-1136","journal-title":"J Biol Chem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"46426","DOI":"10.1038\/srep46426","volume":"7","author":"Van Hoeven N.","year":"2017","unstructured":"Van Hoeven N.; Fox C.B.; Granger B.; Evers T.; Joshi S.W.; Nana G.I.; Evans S.C.; Lin S.; Liang H.; Liang L.; Nakajima R.; Felgner P.L.; Bowen R.A.; Marlenee N.; Hartwig A.; Baldwin S.L.; Coler R.N.; Tomai M.; Elvecrog J.; Reed S.G.; Carter D.; A Formulated TLR7\/8 agonist is a flexible, highly potent and effective adjuvant for pandemic influenza vaccines. Sci Rep  2017,7(1),46426","journal-title":"Sci Rep"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.3390\/pharmaceutics14102076","volume":"14","author":"Tambunlertchai S.","year":"2022","unstructured":"Tambunlertchai S.; Geary S.M.; Salem A.K.; Topically applied resiquimod versus imiquimod as a potential adjuvant in melanoma treatment. Pharmaceutics  2022,14(10),2076","journal-title":"Pharmaceutics"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673306158240620071438","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/231611\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673306158240620071438","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T10:23:28Z","timestamp":1751624608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/231611\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":105,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673306158240620071438","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-02-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}